Navigation Links
International study finds lower-dose IUDs are safe and effective
Date:12/5/2013

LOS ANGELES (Dec. 5, 2013) In a finding that could expand the use of one of the most effective forms of birth control, two intrauterine contraceptive systems that had lower doses of the contraceptive hormone, levonorgestrel, were found to be safe and effective in preventing pregnancies, according to an international study that included researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed).

The study, published in the December issue of the journal, Obstetrics & Gynecology, noted that the currently available higher-dose intrauterine contraceptive system has increased in popularity since its introduction in the U.S. in 2001 because of its safety, effectiveness and convenience: It doesn't require a woman to take a pill or take any specific actions immediately prior to intercourse.

But a recent survey found 60% of physicians rarely prescribe IUDs for women who have not borne children. In many European countries, they're only prescribed for women who have completed their families. Another recent study in U.S. family planning clinics found placement of the higher-dose intrauterine contraceptive systems failed in 19% of women who had not borne children.

The lower-dose intrauterine contraceptive systems are smaller than the higher-dose systems and, the study found, they are easier to use in women who have not delivered a child or have delivered only by cesarean section. Researchers at 138 centers across 11 countries tested the devices in nearly 3,000 women and rated placement of the smaller devices as "easy" in 90% of the women.

"By demonstrating the safety and efficacy of low-dose intrauterine contraceptive devices, this study will help expand the contraceptive options available to women who have not had children before," said Anita Nelson, MD, an LA BioMed lead researcher and corresponding author of the study. "Additionally, a lower dose system may be preferable to women who
'/>"/>

Contact: Laura Mecoy
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert

Page: 1 2

Related medicine news :

1. International breast health global summit will focus on supportive care and quality of life
2. International conference to explore health of descendants of transatlantic slave trade
3. Kessler Foundation researchers present at first International Congress on Cognition in MS
4. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
5. Nobel laureate to keynote international pharmaceutical conference at URI
6. International Nanomedicine Conference bound for Sydney: July 2-4, 2012
7. June 2012 marks a milestone for International Urogynecology Associates as Dr. Robert D. Moore and Dr. John R. Miklos perform their 24th Neovagina Surgery in 24 months
8. Heavy Duty Alternators and Starters Expert Elreg Distributors Ltd. Meets Needs of International Market with Launch of Spanish Website
9. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
10. RMAX International to donate Recuper8 - a free, health - restoring program to Everyone in Uniform
11. International symposium on veterinary rehabilitation and physical therapy to be held in Vienna
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 The American ... U.S. Sens. Thad Cochran (R-MS) and Roger Wicker ... in telemedicine coverage under Medicare, Medicaid and Federal ... both Mississippi Republicans, introduced the Telehealth Enhancement Act ... House version, H.R. 3306, introduced by Rep. Gregg ...
(Date:7/30/2014)... Portland, OR (PRWEB) July 30, 2014 ... and evaluating the quality of care that their ... company’s CEO, Mr. Andrew Rowe, discussed the importance ... order to improve physician performance and quality of ... for effective practitioner evaluation, Mr. Rowe elaborated on ...
(Date:7/30/2014)... Aquarium Research Institute (MBARI) have observed a deep-sea octopus ... than any other known animal. Throughout this time, the ... predators. This amazing feat represents an evolutionary balancing act ... plenty of time to develop within their eggs, and ... or no food. , Every few months for the ...
(Date:7/30/2014)... Frozen shoulder (Adhesive capsulitis) affects 10-20 percent of ... nasty condition which occurs most frequently in people between the ... two and half years if not treated. , Adhesive capsulitis ... reason: it can render your shoulder so stiff, it's almost ... aren't in too much pain to get dressed in the ...
(Date:7/30/2014)... 2014 (HealthDay News) -- For patients with asthma, just ... trigger airway inflammation for at least 24 hours, a ... smell, but also what you think you smell," study ... Center in Philadelphia, said in a Monell news release. ... fragrances. When we expect that an odor is harmful, ...
Breaking Medicine News(10 mins):Health News:ATA Applauds Senators’ Push for Federal Telemedicine Improvements 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 3Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 2Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Even Thinking an Odor is Harmful May Spur Asthma Symptoms 2
... Featured Panelist ... PHILADELPHIA, Sept. 16 Stop Falls Now! That is not just,a ... 2008,Annual Meeting and Exposition, but is now a reality. For the ... at this show., Beyond slogans or theory, LTC providers will ...
... Sept. 16 The National,Autism Association announced ... the first recipients of Project Lifesaver funding ... to counter the rise in,wandering-related deaths among ... a nationwide tracking program established to,quickly locate ...
... improved motor functioning, study finds , , TUESDAY, Sept. ... HDACi 4b reversed Huntington,s disease symptoms in mice ... at the Scripps Research Institute in California. ... affects people,s movement and thinking ability. There is ...
... Coalition Launched to Lobby for Improved Nurse Staffing in ... announced his support for state legislation that would increase ... Speaking at a press,conference called by the RN2RN Network, ... to take action to protect patients., "Given estimates ...
... Pa., Sept. 16 Particle Sciences, Inc.,announces the ... system for,increasing the density of sintered metal products. ... in a way that decreases needed,injection forces, decreases ... is based on a proprietary coating,applied to the ...
... percent increase in the number of air ambulance flights they operated ... ... AZ (PRWEB) September 16, 2008 -- Angel MedFlight Worldwide www.angelmedflight.com ... number of air ambulance flights they operated in the second quarter ...
Cached Medicine News:Health News:Samarion(SM) to Demonstrate Unprecedented Fall Prevention Component of Enterprise Quality Improvement System for LTC Facilities at the AAHSA 2008 Annual Meeting & Exposition 2Health News:National Autism Association's 'FOUND' Provides Funds to Union County Sheriff's Office for Project Lifesaver Equipment 2Health News:Compound Reverses Huntington's Symptoms in Mice 2Health News:Lt. Gov. Quinn Backs Patient Care Reforms 2Health News:Lt. Gov. Quinn Backs Patient Care Reforms 3Health News:Particle Sciences Develops Methods for Increasing Quality of Sintered Metal Products and for Coating Surfaces with Metal Oxide Films 2Health News:Substantial Second Quarter Surge for Angel MedFlight Worldwide Air Ambulance Services 2
(Date:7/30/2014)... 30, 2014   Unique Pizza and Subs ... Pink: UPZS), a Delaware Corporation, is pleased to ... Larasan Pharmaceutical Corporation ("Larasan"), a nature-based pharmaceutical company that ... agreement, US-based Larasan will work with Unique to ... through Larasan,s vast distribution network throughout ...
(Date:7/30/2014)... and KISSING, Germany , July 30, ... a single use and computer-assisted ("robotic") colonoscopy system, today ... a worldwide recognized medical device executive, as a new ... Shamir is a highly respected global visionary in the ... served as President and Chief Executive Officer at Given ...
(Date:7/30/2014)... N.Y. and PARIS , ... REGN ) and Sanofi (EURONEXT: SAN and NYSE: ... Phase 3 ODYSSEY trials of alirocumab in people with ... percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) ...  Alirocumab is an investigational monoclonal antibody targeting PCSK9 (proprotein ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8
... N.C., Aug. 12, 2011 Although medical devices ... complexities require medical device companies to invest more ... generic pharmaceutical products.   Tactical marketers ... activities, such as troubleshooting post-launch and managing product ...
... Misonix, Inc. (NASDAQ: MSON ), a ... innovative therapeutic ultrasonic products worldwide for wound debridement, ... other surgical and medical applications, has entered into ... Solutions Australasia Pty. Ltd., based in Newport, Victoria, ...
Cached Medicine Technology:Medical Device Marketing Groups Focus More Resources on Tactical Activities When Compared to Pharmaceutical Counterparts 2Misonix Announces New Distribution Agreement for Australia and New Zealand 2Misonix Announces New Distribution Agreement for Australia and New Zealand 3
Magnetic Farnsworth D15 kit Magnets move the color disks. Protects disks from fingerprints. Keeps all the disks in one place. Clear glass insures accurate color perception. Makes color testing fun....
... modification of the Farnsworth-Munsell 100 Hue Test. It ... the in-depth study of a color vision defect. ... ease or difficulty in distinguishing color differences in ... 15 color reference caps with Munsell notations, plus ...
Spanish HRR/Amsler combination with Spanish and English directions for both HRR and amsler tests plus occluding glasses....
... HRR 4th edition pseudoisochromatic test from Richmond Products ... plates and the 14 diagnostic series for a ... has its own tab for easy and clean ... of instructions in English and a laminated copy ...
Medicine Products: